1. Gallium SPECT/CT in lymphoma: the ups and downs of functional imaging

   • Rachel Bar-Shalom

   Editorial Commentary 09 September 2005 Pages: 1247 - 1249

2. Osteoblastic bone metastases in breast cancer: is not seeing believing?

   • Ignac Fogelman

   Editorial Commentary 20 August 2005 Pages: 1250 - 1252

3. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer

   • Takako Nakai
   • Chio Okuyama
   • Tsunehiko Nishimura

   Original Article 20 August 2005 Pages: 1253 - 1258

   

4. Comparison of ¹⁸F-FDG and ⁶⁸Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus

   • Tatu J. Mäkinen
   • Petteri Lankinen
   • Anne Roivainen

   Original Article 09 July 2005 Pages: 1259 - 1268

   

5. A simplified analysis of [¹⁸F]3′-deoxy-3′-fluorothymidine metabolism and retention

   • Anthony F. Shields
   • David A. Briston
   • Otto Muzik

   Original Article 01 July 2005 Pages: 1269 - 1275

6. Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy

   • Wouter V. Vogel
   • Bart M. Wensing
   • Wim J. G. Oyen

   Original Article 16 July 2005 Pages: 1276 - 1282

   

7. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients

   • Pilar Paredes
   • Sergi Vidal-Sicart
   • Francesca Pons

   Original Article 09 July 2005 Pages: 1283 - 1287

   

8. ¹¹¹In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy

   • Astrid Capello
   • Eric Krenning
   • Marion de Jong

   Original Article 15 July 2005 Pages: 1288 - 1295

   

9. In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma

   • M. Nestor
   • M. Persson
   • V. Tolmachev

   Original Article 19 July 2005 Pages: 1296 - 1304

   

10. [¹²³I]Iodobenzamide binding to the rat dopamine D₂ receptor in competition with haloperidol and endogenous dopamine—an in vivo imaging study with a dedicated small animal SPECT

    • Susanne Nikolaus
    • Rolf Larisch
    • Hans-Wilhelm Müller

    Original Article 08 July 2005 Pages: 1305 - 1310

    

11. Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy

    • Glenn P. Ollenberger
    • Amanda J. Byrne
    • Andrew M. Scott

    Original Article 03 August 2005 Pages: 1311 - 1316

    

12. Abnormal response to inotropic stimulation in young asymptomatic type I diabetic patients demonstrated by serial gated myocardial perfusion SPECT imaging

    • C. Weytjens
    • B. Cosyns
    • P. R. Franken

    Original Article 17 August 2005 Pages: 1317 - 1323

    

13. Demonstration of pulmonary β₂-adrenergic receptor binding in vivo with [¹⁸F]fluoroethyl-fenoterol in a guinea pig model

    • A. Helisch
    • E. Schirrmacher
    • P. Bartenstein

    Short Communication 31 August 2005 Pages: 1324 - 1328

    

14. Measuring SSRI occupancy of SERT using the novel tracer [¹²³I]ADAM: a SPECT validation study

    • Kjell Erlandsson
    • Tharani Sivananthan
    • Peter J. Ell

    Molecular Imaging 26 August 2005 Pages: 1329 - 1336

    

15. Multislice CT coronary angiography: how to do it and what is the current clinical performance?

    • Filippo Cademartiri
    • Joanne D. Schuijf
    • Pim J. de Feyter

    Occasional Survey 03 August 2005 Pages: 1337 - 1347

    

16. Regressive DOTA labelling performance with indium-111 and yttrium-90 over a week of use

    • James E. S. Hainsworth
    • Stephen J. Mather

    Letter to the Editor 03 September 2005 Pages: 1348 - 1348

17. Metastatic melanoma to the heart

    • Frank V. Schraml
    • William M. Yudt
    • Vincent B. Ho

    Image of the Month 09 September 2005 Pages: 1349 - 1349

    

18. November 2005

    Announcements 03 November 2005 Pages: 1350 - 1350